Browsing Tag
Inventta Institute
1 post
How Brazilian drugmaker Blau Farmacêutica quietly built a pembrolizumab biosimilar that could challenge Big Pharma
Blau Farmacêutica completes Brazil’s first full pembrolizumab biosimilar. Find out how this could reshape global immunotherapy access and biosimilar strategy.